Government Investigation Finds Flaws In the FDA’s Orphan Drug Program
This story also ran on NPR. This story can be republished for free (details). The Food and Drug Administration has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials revealed in a report Friday. The Government Accountability Office, which spent more than a year investigating the… Read More »